Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 173.65
+4.35 (2.57%)
Jul 24, 2026, 5:30 PM CET
Galderma Group AG Stock Forecast
Stock Price Forecast
According to 18 analysts polled by S&P Global, Galderma Group AG stock has a consensus rating of "Buy" and an average price target of CHF 191.19. The average 1-year stock price forecast is 10.10% higher than the current stock price, while the lowest is CHF 130.23 (-25.00%) and the highest is CHF 263.32 (+51.64%).
Price Target: CHF 191.19 (+10.10%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Galderma Group AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 11 | 11 | 11 | 11 | 11 |
| Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 1 | 1 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 1 | 1 | 1 | 1 |
| Total | 14 | 18 | 18 | 18 | 18 | 18 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
Shyam Kotadia Goldman Sachs No rating | Goldman Sachs | Buy Maintains CHF 200.00 → CHF 203.00 | Buy | Maintains | CHF 200.00 → CHF 203.00 | +16.90% | Jul 24, 2026 |
| UBS | UBS | Buy Maintains CHF 200.00 | Buy | Maintains | CHF 200.00 | +15.17% | Jul 24, 2026 |
| Barclays | Barclays | Buy Reiterates CHF 200.00 → CHF 210.00 | Buy | Reiterates | CHF 200.00 → CHF 210.00 | +20.93% | Jul 24, 2026 |
| Jefferies | Jefferies | Buy Maintains CHF 205.00 | Buy | Maintains | CHF 205.00 | +18.05% | Jul 23, 2026 |
| RBC Capital | RBC Capital | Hold Maintains CHF 155.00 → CHF 175.00 | Hold | Maintains | CHF 155.00 → CHF 175.00 | +0.78% | Jul 8, 2026 |
Financial Forecast
Revenue This Year
6.39B
from 5.24B
Increased by 22.01%
Revenue Next Year
7.40B
from 6.39B
Increased by 15.75%
EPS This Year
4.70
from 3.69
Increased by 27.44%
EPS Next Year
6.28
from 4.70
Increased by 33.49%
EPS and Forward PE are based on non-GAAP adjusted numbers.